SeaSpine appointed Patrick Keran to general counsel.
Spinal Tech
Stryker's Interventional Spine business received FDA clearance for its VertaPlex HV, which treats sacral insufficiency fractures.
The non-fusion spinal devices market is expected to continue growing through 2025, according to a Future Market Insights report.
Integra LifeSciences Holdings' company shares increased 0.97 percent during the week of Oct. 12 to Oct. 16, according to Insider Trading Report.
IlluminOss Medical recently entered into an agreement with Orthovative to distribute the IlluminOss System in Germany.
Amendia has entered into a strategic venture with Promimic.
Ziehm Imaging and the Navigation Division of Stryker have signed a co-marketing agreement.
The FDA approved an expansion for the InVivo pilot study for the investigational Neuro-Spinal Scaffold.
Meditech Spine's Talos interbody devices have received FDA clearance for use with allograft comprised of cancellous or corticocancellous bone graft.
IlluminOss Medical named Manny Avila CEO.
